Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Veterinary Vaccines Market, by Route of Administration
1.4.2 Europe Veterinary Vaccines Market, by Type
1.4.3 Europe Veterinary Vaccines Market, by Technology
1.4.4 Europe Veterinary Vaccines Market, by Distribution Channel
1.4.5 Europe Veterinary Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jun – 2022, Dec) Leading Players
Chapter 4. Europe Veterinary Vaccines Market by Route of Administration
4.1 Europe Injection Vaccines Market by Country
4.2 Europe Oral Vaccines Market by Country
4.3 Europe Intranasal/Spray Vaccines Market by Country
Chapter 5. Europe Veterinary Vaccines Market by Type
5.1 Europe Livestock Vaccines Market by Country
5.2 Europe Porcine Vaccines Market by Country
5.3 Europe Companion Animal Vaccines Market by Country
5.4 Europe Poultry Vaccines Market by Country
5.5 Europe Aquaculture Vaccines Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Veterinary Vaccines Market by Technology
6.1 Europe Live Attenuated Vaccines Market by Country
6.2 Europe Inactivated Vaccines Market by Country
6.3 Europe Toxoid Vaccines Market by Country
6.4 Europe Recombinant Vaccines Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Veterinary Vaccines Market by Distribution Channel
7.1 Europe Veterinary Hospitals Market by Country
7.2 Europe Veterinary Clinics Market by Country
7.3 Europe Retail Pharmacies Market by Country
Chapter 8. Europe Veterinary Vaccines Market by Country
8.1 Germany Veterinary Vaccines Market
8.1.1 Germany Veterinary Vaccines Market by Route of Administration
8.1.2 Germany Veterinary Vaccines Market by Type
8.1.3 Germany Veterinary Vaccines Market by Technology
8.1.4 Germany Veterinary Vaccines Market by Distribution Channel
8.2 UK Veterinary Vaccines Market
8.2.1 UK Veterinary Vaccines Market by Route of Administration
8.2.2 UK Veterinary Vaccines Market by Type
8.2.3 UK Veterinary Vaccines Market by Technology
8.2.4 UK Veterinary Vaccines Market by Distribution Channel
8.3 France Veterinary Vaccines Market
8.3.1 France Veterinary Vaccines Market by Route of Administration
8.3.2 France Veterinary Vaccines Market by Type
8.3.3 France Veterinary Vaccines Market by Technology
8.3.4 France Veterinary Vaccines Market by Distribution Channel
8.4 Russia Veterinary Vaccines Market
8.4.1 Russia Veterinary Vaccines Market by Route of Administration
8.4.2 Russia Veterinary Vaccines Market by Type
8.4.3 Russia Veterinary Vaccines Market by Technology
8.4.4 Russia Veterinary Vaccines Market by Distribution Channel
8.5 Spain Veterinary Vaccines Market
8.5.1 Spain Veterinary Vaccines Market by Route of Administration
8.5.2 Spain Veterinary Vaccines Market by Type
8.5.3 Spain Veterinary Vaccines Market by Technology
8.5.4 Spain Veterinary Vaccines Market by Distribution Channel
8.6 Italy Veterinary Vaccines Market
8.6.1 Italy Veterinary Vaccines Market by Route of Administration
8.6.2 Italy Veterinary Vaccines Market by Type
8.6.3 Italy Veterinary Vaccines Market by Technology
8.6.4 Italy Veterinary Vaccines Market by Distribution Channel
8.7 Rest of Europe Veterinary Vaccines Market
8.7.1 Rest of Europe Veterinary Vaccines Market by Route of Administration
8.7.2 Rest of Europe Veterinary Vaccines Market by Type
8.7.3 Rest of Europe Veterinary Vaccines Market by Technology
8.7.4 Rest of Europe Veterinary Vaccines Market by Distribution Channel
Chapter 9. Company Profiles
9.1 Zoetis, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Acquisition and Mergers:
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Boehringer Ingelheim International Gmbh
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Elanco Animal Health, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 Virbac
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 Ceva Santé Animale
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Joint-Ventures:
9.6.2.2 Product Launches and Product Expansions:
9.6.2.3 Acquisition and Mergers:
9.7 Neogen Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisition and Mergers:
9.8 Intas Pharmaceutical Ltd.
9.8.1 Company Overview
9.9 Laboratoire LCV
9.9.1 Company Overview